Suboptimal medication adherence in Parkinson's disease
- 21 July 2005
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 20 (11) , 1502-1507
Abstract
Patients take less medication than prescribed in many disease areas but evidence for suboptimal therapy adherence in Parkinson's disease (PD) is limited. A single‐center observational study of antiparkinsonian medication was undertaken using electronic monitoring (MEMS; Aardex, Zug, Switzerland) over 3 months. Of 68 patients approached, 6 declined and 8 dropped out, leaving 54 patients (taking 117 preparations) with available data. Poorer compliance was associated significantly with younger age, with taking more antiparkinsonian tablets per day, with higher depression scores, and with poorer quality of life. Of the 54 evaluable patients, 11 (20%) had average total compliance of under 80% (underusers) and 43 (80%) had average total compliance of over 80% (satisfactory adherence). Underusers had median total compliance of 65% (interquartile range, 37–74) versus 98% (interquartile range, 93–102) in the satisfactory adherence group. Timing compliance (number of doses taken in the correct time interval) was poor in both underusers (median, 11%; interquartile range, 2–20) and those with satisfactory adherence (median, 25%; interquartile range, 11–73). In conclusion, poorer compliance is associated with younger age, depression, and more tablets per day, and one‐fifth of PD patients underuse medication. Consideration of drug therapy adherence has implications in the management of PD. © 2005 Movement Disorder SocietyKeywords
This publication has 46 references indexed in Scilit:
- Poster session 3, Abstracts 695–815Movement Disorders, 2004
- A wolf in sheep's clothing: a critical look at the ethics of drug takingBMJ, 2003
- Factors impacting on quality of life in Parkinson's disease: Results from an international surveyMovement Disorders, 2002
- Dose Frequency and Dose Interval Compliance with Multiple Antiepileptic Medications During a Controlled Clinical TrialEpilepsia, 1995
- Health promotion in primary care: Physician-patient communication and decision making about prescription medicationsSocial Science & Medicine, 1995
- Controlled Release Levodopa/Carbidopa 25/100 (Sinemet CR 25/100)Clinical Neuropharmacology, 1994
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982
- Can simple clinical measurements detect patient noncompliance?Hypertension, 1980